|
|
Article: Orchid Receives First Approval to Use SNP Technology as Primary Markers for Paternity Testing.
- Article from:
- PR Newswire
- Article date:
- May 7, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Orchid BioSciences, Inc. today announced that it is the first company to receive approval from the American Association of Blood Banks (AABB) to use single nucleotide polymorphisms (SNPs) as stand-alone genetic markers in its Orchid GeneScreen paternity testing operations. Orchid is replacing conventional short tandem repeat, or STR techniques with more cost-effective methods that use its SNP genotyping technology to achieve additional efficiencies and further improve quality and service in its paternity testing operations. The AABB is the leading standard-setting organization for parentage testing in the U.S.
Orchid expects the application of its technology to ...